We are your partner of choice for active pharmaceutical ingredients and advanced intermediates contract manufacturing to the life sciences community. Zhejiang Raybow Pharmaceutical Co. Ltd. is the CDMO division of Zhejiang Jiuzhou Pharmaceautical Co.Ltd.(Headquarter) focused on API development and manufacturing, which is located in the Linhai county, Taizhou City, Zhejiang province of China. The state of art manufacturing facility has R&D center, scale up plant and GMP production workshops. Raybow is a world leader in the development and manufacturing of Carbamazepine APIs capturing 40% international market.


Worldwide regulatory inspection record
  • Americas
    2004, 2007, 2011, 2013, 2014, 2016 (2 audits)
  • Europe
    2007, 2014
  • Asia
    2000, 2002, 2004, 2009, 2011, 2014
  • 2016 Establishes 2 strategic business divisions, Zhejiang Raybow Pharmaceutical Co.Ltd is confirmed as key legal entity for Jiuzhou CDMO Division.
  • 2014 IPO on Shanghai Stack Exchange Stock Code 603456
  • 1998 Dongshan Chemical Factory evolves into the Jiuzhou Pharmaceutical Brand

We strive to meet and exceed regulatory and customer’s requirements, provide value added products and service so as to become a world-class pharmaceutical company.

  • June 19-23,2017
    Shanghai News Int’l Expo Center(SNIEC),Shanghai.China
  • June 19-23,2017
    Shanghai News Int’l Expo Center(SNIEC),Shanghai.China